Valentine Charlton-Menys
93 works · 6,428 citations · h-index 27
Top works
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
- Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
- Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
- Sequencing of the Reannotated LMNB2 Gene Reveals Novel Mutations in Patients with Acquired Partial Lipodystrophy
- Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)
- Targets of Statin Therapy: LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)
- Alstrom syndrome (OMIM 203800): a case report and literature review
- Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes
- Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
- Human cholesterol metabolism and therapeutic molecules
- Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis
- Macroaggregation of Platelets in Plasma, as Distinct from Microaggregation in Whole Blood (and Plasma), as Determined Using Optical Aggregometry and Platelet Counting respectively, is Specifically Impaired following Cardiopulmonary Bypass in Man
- Variation in paraoxonase-1 activity and atherosclerosis
- Heparin-induced platelet dysfunction and cardiopulmonary bypass
- Glycation as an atherogenic modification of LDL
- Squalene Synthase Inhibitors
- Semiautomated Method for Determination of Serum Paraoxonase Activity Using Paraoxon as Substrate
- Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro
- Platelet 5-Hydroxytryptamine is Decreased in a Preliminary Group of Depressed Patients Receiving the 5-Hydroxytryptamine Re-Uptake Inhibiting Drug Fluoxetine
- Decorin GAG Synthesis and TGF-β Signaling Mediate Ox-LDL–Induced Mineralization of Human Vascular Smooth Muscle Cells